본문 바로가기
about us
Dedicated to revolutionizing new drug discovery and development

Message from CEO

LCB is paving a new path forward to revolutionize the innovative novel therapies
Yong-Zu Kim, Ph.D.
CEO of

LegoChem Biosciences

My journey in drug research and development began thirty years ago, with the dream of creating new drugs for global markets. For twenty-three years, I have devoted myself R&D of new drugs as the head of a large corporate research institut. Since founding LegoChem Biosciences in 2006, I have been striving my utmost to realize the lifelong mission to this day.
We’re driven by this singular vision dedicated to revolutionizing new drug discovery and development, by leveraging our expertise in medicinal chemistry to build a portfolio of new drug for the global market.

Developing new global drugs requires immense capital and various specialized knowledge, as well as overcoming the risk of countless failures. Nonetheless, I firmly believe that we can achieve this dream. LCB's strategy focuses on enhancing our core proprietary technologies and supplementing inadequacies through open innovation with world-class partners. I believe that I hope to share the fruit of our efforts with every one of our devoted researchers. Let me conclude the message with my management philosophy and the motto that I share with all members of LCB on new drug development

"A dream you dream alone is only a dream. A dream you dream together is reality."

Yong-Zu Kim
CEO of LegoChem Biosciences
ceo sign